PGHLPharmaceuticals
Procter & Gamble Health Ltd — Quarterly Results & Earnings
₹4798.80
-1.61%
Profit Growth YoY7.54%Latest quarter
Sales Growth YoY3.67%Latest quarter
Sales CAGR 5Y0.16%5 year compound
Profit CAGR 5Y8.11%5 year compound
📋
Quarterly Performance
YoY Profit Growth+7.54%
📈 Moderate growth
YoY Sales Growth+3.67%
📈 Moderate growth
OPM 5Y Average
26.17%Operating profit margin
EPS Growth 5Y
8.11%Interest Coverage
785.71Higher = safer debt servicing
ROE
36.42%ROCE
47.75%💡
Growth Analysis
Procter & Gamble Health Ltd reported YoY profit growth of 7.54% and revenue growth of 3.67% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 0.16% and profits at 8.11% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Procter & Gamble Health Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.